Test results show sustainable retinoid-alternative ingredient ‘provides benefits without skin irritation’



As reported by research firm Future Market Insights​, “the global demand for retinoids is expected to rise at a healthy CAGR of 5.4% per year” with a projected market value of $2.5bn by 2023. Products containing retinoids like retinol, adapalene and tretinoin are in increasing demand due to their efficacy in addressing acne and pigmentary skin conditions like post-inflammatory hyperpigmentation (PIH). However, regular use of retinoid products can also result in well-known side effects like increased sun sensitivity, dryness, and skin peeling.

In response to these retinoid-related issues, specialty chemical manufacturer Lubrizol Life Science has recently released test results backing the efficacy of its retinoid-alternative ingredient Stevisse.

To learn more about the R&D process behind this advanced botanical ingredient, including the challenges overcome to successfully formulate Stevisse, as well as the results of the recent testing, we interviewed Bianca McCarthy, Ph.D, who is the Global Marketing Manager, Lipotec Active Ingredients at Lubrizol Life Science for her insights.

Formulation and R&D process

The initial interest in developing Stevisse lay in the Lubrizol Life Science R&D team’s desire to “develop an effective, natural, milder and gentler alternative to retinoids,” said McCarthy. In addition to effectively addressing PIH and other related issues, “retinoids have shown promise in minimizing skin aging,” she explained.

However, considering their undesirable side effects, which can also include “itching and burning sensations, erythema and scaling of the skin,” she said, the researchers therefore “identified the opportunity to develop a natural alternative to retinoids that was gentler on the skin without sacrificing efficacy.”



Source link

About The Author